EP1257255A4 - Therapeutic product, use and formulation thereof - Google Patents

Therapeutic product, use and formulation thereof

Info

Publication number
EP1257255A4
EP1257255A4 EP20010914449 EP01914449A EP1257255A4 EP 1257255 A4 EP1257255 A4 EP 1257255A4 EP 20010914449 EP20010914449 EP 20010914449 EP 01914449 A EP01914449 A EP 01914449A EP 1257255 A4 EP1257255 A4 EP 1257255A4
Authority
EP
European Patent Office
Prior art keywords
formulation
therapeutic product
therapeutic
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP20010914449
Other languages
German (de)
French (fr)
Other versions
EP1257255A1 (en
Inventor
Edward M Rudnic
James D Isbister
Donald J Treacy Jr
Sandra E Wassink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Inc
Original Assignee
Advancis Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancis Pharmaceutical Corp filed Critical Advancis Pharmaceutical Corp
Publication of EP1257255A1 publication Critical patent/EP1257255A1/en
Publication of EP1257255A4 publication Critical patent/EP1257255A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
EP20010914449 2000-02-24 2001-02-22 Therapeutic product, use and formulation thereof Ceased EP1257255A4 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US687237 1984-12-28
US687236 1996-07-25
US18454600P 2000-02-24 2000-02-24
US184546P 2000-02-24
US68723700A 2000-10-13 2000-10-13
US68723600A 2000-10-13 2000-10-13
US68723500A 2000-10-13 2000-10-13
US68722900A 2000-10-13 2000-10-13
US687235 2000-10-13
US687229 2000-10-13
PCT/US2001/005758 WO2001062229A1 (en) 2000-02-24 2001-02-22 Therapeutic product, use and formulation thereof

Publications (2)

Publication Number Publication Date
EP1257255A1 EP1257255A1 (en) 2002-11-20
EP1257255A4 true EP1257255A4 (en) 2008-07-30

Family

ID=27539122

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20010914449 Ceased EP1257255A4 (en) 2000-02-24 2001-02-22 Therapeutic product, use and formulation thereof

Country Status (5)

Country Link
EP (1) EP1257255A4 (en)
JP (2) JP2003523378A (en)
AU (1) AU2001239838A1 (en)
CA (1) CA2400784C (en)
WO (1) WO2001062229A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AR034813A1 (en) † 2001-07-20 2004-03-17 Novartis Ag PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
US7037523B2 (en) 2001-11-02 2006-05-02 Wockhardt Limited Controlled release compositions for macrolide antimicrobial agents
JP4221299B2 (en) * 2001-12-21 2009-02-12 ビーオパルトナーズ ゲーエムベーハー Ribavirin granules for film tablet production
CZ298224B6 (en) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Pharmaceutical composition containing ribavirin as active substance and process for its preparation
EP1648415A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotic product, use and formulation thereof
WO2005009364A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US7348144B2 (en) * 2003-08-13 2008-03-25 Agilent Technologies, Inc. Methods and system for multi-drug treatment discovery
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1663169A4 (en) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp Enhanced absorption of modified release dosage forms
CA2636339C (en) * 2006-01-19 2014-07-08 Dow Global Technologies Inc. Biologically active composition comprising ethylcellulose
CA2635606A1 (en) * 2006-12-04 2008-06-12 Advancis Pharmaceutical Corporation Modified release amoxicillin products
WO2009049648A2 (en) * 2007-10-17 2009-04-23 Pharmathen S.A. Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222914A1 (en) * 1985-03-14 1987-05-27 Teysan Pharmaceuticals Co., Ltd. Stabilized composite granular antibiotic preparation
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5672359A (en) * 1993-07-21 1997-09-30 The University Of Kentucky Research Foundation Multicompartment hard capsule with control release properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them
JPS601128A (en) * 1983-06-15 1985-01-07 Shionogi & Co Ltd Long-acting cefaclor preparation
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5827531A (en) * 1994-12-02 1998-10-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microcapsules and methods for making
DE19718012C1 (en) * 1997-04-29 1998-10-08 Jenapharm Gmbh Process for the production of orally applicable solid pharmaceutical forms with controlled release of active substances
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222914A1 (en) * 1985-03-14 1987-05-27 Teysan Pharmaceuticals Co., Ltd. Stabilized composite granular antibiotic preparation
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
US5672359A (en) * 1993-07-21 1997-09-30 The University Of Kentucky Research Foundation Multicompartment hard capsule with control release properties

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0162229A1 *

Also Published As

Publication number Publication date
CA2400784C (en) 2009-05-19
JP2012001528A (en) 2012-01-05
JP2003523378A (en) 2003-08-05
CA2400784A1 (en) 2001-08-30
WO2001062229A1 (en) 2001-08-30
AU2001239838A1 (en) 2001-09-03
JP5377465B2 (en) 2013-12-25
EP1257255A1 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
HRP20040027A2 (en) 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
MXPA02010914A (en) Anthranyl amides and their use as medicaments.
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
EP1257255A4 (en) Therapeutic product, use and formulation thereof
HRP20010655B1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
GB0101035D0 (en) Formulation and use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
HUP0303260A3 (en) Agrochemical formulations, preparation and use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
IL163683A0 (en) Substituted 3-phenyl-5-alkoxy-1,3,4,-oxadiazol-2-ones, their preparation and use in medicaments
IL150237A0 (en) Benzophenone glycopyranosides, preparation and therapeutic use
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
GB0023473D0 (en) Therapeutic use and formulation
AU7660601A (en) Pseudo-metalloproteins, their preparation and use
SI1240177T1 (en) Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use
GB9926528D0 (en) Therapeutic use and formulation
AU2001237517A1 (en) Haloimidazole derivatives, their preparation and therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020824

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: TREACY, DONALD, J., JR.

Inventor name: WASSINK, SANDRA, E.

Inventor name: RUDNIC, EDWARD, M.

Inventor name: ISBISTER, JAMES, D.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ADVANCIS PHARMACEUTICAL CORPORATION

A4 Supplementary search report drawn up and despatched

Effective date: 20080630

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.

17Q First examination report despatched

Effective date: 20081017

R17C First examination report despatched (corrected)

Effective date: 20091009

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SHIONOGI INC.

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20150305